356 related articles for article (PubMed ID: 22682059)
21. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
Czyz A; Lewandowski K; Kroll R; Komarnicki M
Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
[TBL] [Abstract][Full Text] [Related]
22. Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Laport GG; Alvarnas JC; Palmer JM; Snyder DS; Slovak ML; Cherry AM; Wong RM; Negrin RS; Blume KG; Forman SJ
Blood; 2008 Aug; 112(3):903-9. PubMed ID: 18519812
[TBL] [Abstract][Full Text] [Related]
23. Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias.
Shimoni A; Kröger N; Zander AR; Rowe JM; Hardan I; Avigdor A; Yeshurun M; Ben-Bassat I; Nagler A
Leukemia; 2003 Feb; 17(2):290-7. PubMed ID: 12592325
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
25. Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions.
Yoshimitsu M; Fujiwara H; Ozaki A; Hamada H; Matsushita K; Arima N; Tei C
Int J Hematol; 2008 Oct; 88(3):331-335. PubMed ID: 18696183
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Fagioli F; Zecca M; Rognoni C; Lanino E; Balduzzi A; Berger M; Messina C; Favre C; Rabusin M; Lo Nigro L; Masetti R; Prete A; Locatelli F;
Biol Blood Marrow Transplant; 2012 Jun; 18(6):852-60. PubMed ID: 22019726
[TBL] [Abstract][Full Text] [Related]
27. Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.
de Labarthe A; Rousselot P; Huguet-Rigal F; Delabesse E; Witz F; Maury S; Réa D; Cayuela JM; Vekemans MC; Reman O; Buzyn A; Pigneux A; Escoffre M; Chalandon Y; MacIntyre E; Lhéritier V; Vernant JP; Thomas X; Ifrah N; Dombret H;
Blood; 2007 Feb; 109(4):1408-13. PubMed ID: 17062730
[TBL] [Abstract][Full Text] [Related]
28. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
Biondi A; Schrappe M; De Lorenzo P; Castor A; Lucchini G; Gandemer V; Pieters R; Stary J; Escherich G; Campbell M; Li CK; Vora A; Aricò M; Röttgers S; Saha V; Valsecchi MG
Lancet Oncol; 2012 Sep; 13(9):936-45. PubMed ID: 22898679
[TBL] [Abstract][Full Text] [Related]
29. Administration of imatinib in the first 90 days after allogeneic hematopoietic cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Shi HX; Han W; Zhan XH; Wang Y; Zhao T; Huang XJ
Chin Med J (Engl); 2011 Jan; 124(2):246-52. PubMed ID: 21362375
[TBL] [Abstract][Full Text] [Related]
30. Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Wassmann B; Pfeifer H; Stadler M; Bornhaüser M; Bug G; Scheuring UJ; Brück P; Stelljes M; Schwerdtfeger R; Basara N; Perz J; Bunjes D; Ledderose G; Mahlberg R; Binckebanck A; Gschaidmeier H; Hoelzer D; Ottmann OG
Blood; 2005 Jul; 106(2):458-63. PubMed ID: 15817679
[TBL] [Abstract][Full Text] [Related]
31. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Fielding AK; Rowe JM; Richards SM; Buck G; Moorman AV; Durrant IJ; Marks DI; McMillan AK; Litzow MR; Lazarus HM; Foroni L; Dewald G; Franklin IM; Luger SM; Paietta E; Wiernik PH; Tallman MS; Goldstone AH
Blood; 2009 May; 113(19):4489-96. PubMed ID: 19244158
[TBL] [Abstract][Full Text] [Related]
32. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
[TBL] [Abstract][Full Text] [Related]
33. Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study.
Hulegårdh E; Hägglund H; Ahlberg L; Karlsson K; Karbach H; Markuszewska A; Persson I; Åström M; Hallböök H
Med Oncol; 2014 Aug; 31(8):66. PubMed ID: 24965535
[TBL] [Abstract][Full Text] [Related]
34. A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study.
Liu H; Xuan L; Lin R; Deng L; Fan Z; Nie D; Li X; Liang X; Xu D; Zhang Y; Xu N; Ye J; Jin H; Lin D; Ma L; Sun J; Huang F; Liu Q
Leukemia; 2021 Jul; 35(7):2054-2063. PubMed ID: 33204013
[TBL] [Abstract][Full Text] [Related]
35. Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Nishiwaki S; Miyamura K; Kato C; Terakura S; Ohashi K; Sakamaki H; Nakao S; Harigae H; Kodera Y
Anticancer Res; 2010 Jun; 30(6):2415-8. PubMed ID: 20651401
[TBL] [Abstract][Full Text] [Related]
36. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Akahoshi Y; Nishiwaki S; Mizuta S; Ohashi K; Uchida N; Tanaka M; Fukuda T; Ozawa Y; Takahashi S; Onizuka M; Shiratori S; Nakamae H; Kanda Y; Ichinohe T; Atsuta Y; Kako S;
Cancer Sci; 2019 Oct; 110(10):3255-3266. PubMed ID: 31402561
[TBL] [Abstract][Full Text] [Related]
38. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
Radich J; Gehly G; Lee A; Avery R; Bryant E; Edmands S; Gooley T; Kessler P; Kirk J; Ladne P; Thomas ED; Appelbaum FR
Blood; 1997 Apr; 89(7):2602-9. PubMed ID: 9116308
[TBL] [Abstract][Full Text] [Related]
39. In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib.
Sobrinho-Simões M; Wilczek V; Score J; Cross NC; Apperley JF; Melo JV
Blood; 2010 Aug; 116(8):1329-35. PubMed ID: 20462961
[TBL] [Abstract][Full Text] [Related]
40. Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia.
Mizuta S; Matsuo K; Nishiwaki S; Imai K; Kanamori H; Ohashi K; Fukuda T; Onishi Y; Miyamura K; Takahashi S; Onizuka M; Atsuta Y; Suzuki R; Morishima Y; Kato K; Sakamaki H; Tanaka J
Blood; 2014 Apr; 123(15):2325-32. PubMed ID: 24591204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
